StockDuty ← Dashboard Oct 17, 2026 05:42 AM ET
SignalMacro

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Biotech IPOs City Therapeutics and Iambic headline this week's pricings.

What happened: Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint. Key numbers: $200 million raised; $1.0 billion market cap. Why it matters: City Therapeutics is a Phase 1 biotech, and it headlined the week's pricings alongside Iambic. Coverage: 3 outlets in 24h
Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint.
City Therapeutics is a Phase 1 biotech, and it headlined the week's pricings alongside Iambic.
Sources